A 45-year-old woman known to have end-stage renal disease (ESRD) secondary to type 1 diabetes mellitus came to the clinic for a routine follow-up. She had no complaints but was fou... A 45-year-old woman known to have end-stage renal disease (ESRD) secondary to type 1 diabetes mellitus came to the clinic for a routine follow-up. She had no complaints but was found to have abnormal blood results. Which of the following is the most appropriate management? Sevelamer, Calcitriol, Cinacalcet, Calcium supplementation.
Understand the Problem
The question revolves around the management of a patient with end-stage renal disease (ESRD) and diabetes. It asks which treatment option is most appropriate based on the patient's condition and laboratory findings.
Answer
Sevelamer
The most appropriate management is Sevelamer.
Answer for screen readers
The most appropriate management is Sevelamer.
More Information
In patients with end-stage renal disease (ESRD), especially those on dialysis, there is a tendency for elevated phosphate levels due to impaired phosphate excretion. Sevelamer is a phosphate binder that helps manage hyperphosphatemia by binding phosphate in the gastrointestinal tract and preventing its absorption.
Tips
A common mistake is misidentifying the drug needed based on the common other lab abnormalities. Focus on the aspect of mineral imbalance specific to ESRD.
AI-generated content may contain errors. Please verify critical information
